Sannita W G
Center for Neuroactive Drugs, Institute of Neurophysiopathology of the University, Genoa, Italy.
Neurology. 1992 Oct;42(10):2003-5. doi: 10.1212/wnl.42.10.2003.
Acute, oral administration of 14.3 to 37.5 mg/kg magnesium valproate (peak serum concentrations, 65 to 139 micrograms/ml) increases spike-wave frequency at 2, 3, 4, and 5 hours postdrug, in the absence of hyperammonemia or significant correlations with ammonemia fluctuations. This observation suggests a direct role of valproate on neural activity.